Aviva
SIBN icon

Aviva’s SI-BONE Inc SIBN Stock Holding History

Aviva’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39,522
Closed -$1.26M – 964
2021
Q1 		$1.26M Buy
+39,522
New +$1.22M 0.01% 771

Other funds holding SIBN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aviva's SIBN Position: Q2 2021 in Review

Aviva sold out of SI-BONE Inc (SIBN) in Q2 2021, closing a stake of 39,522 shares — an estimated $1.26M sold.

Aviva first reported a position in SIBN in Q1 2021 and held it in 1 quarter. The position peaked at $1.26M in Q1 2021. 134 funds tracked by Wall St. Rank hold SIBN as of Q2 2021.

  • Aviva reported no remaining SI-BONE Inc position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 39,522 SI-BONE Inc shares in Q2 2021, an estimated $1.26M.
  • Aviva first reported a position in SI-BONE Inc in Q1 2021 and held it in 1 quarter.
  • Aviva's SI-BONE Inc position peaked at $1.26M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held SI-BONE Inc as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.